Biohippo Inc.

Gaithersburg, MD Biohippo Inc.

UEI
S969JZ9MKUH3
CAGE
87SR1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
900 Clopper Rd #140, Gaithersburg, MD 20878, USA
Website
ebiohippo.com
Founded
2017
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Biohippo Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
PLVAP1-CRE-ER mice to study vascular fenestrations in the CNS Contract · 75N95A25P00010 National Institute of Neurological Disorders and Stroke $5,500
Niaaa - animal model construction services Contract · 75N94024P00668 National Institute of Child Health and Human Development $15,000
FOLR2-CRE-2A-tdtomato mice Contract · 75N92B24P00111 National Insititue of Arthritis and Musculoskeletal and Skin Diseases $13,000
This firm fixed price task /delivery/ purchase order is awarded for animal strain license to biohippo… Contract · 75N94024P00628 National Institute of Child Health and Human Development $12,000
Research animal - custom conditional knockout mouse Contract · 75N95D24P00097 National Institute on Aging $24,500

About Biohippo Inc.

Biohippo Inc. is a self-certified small disadvantaged business registered in SAM.gov since December 6, 2018, with an active registration until August 8, 2025. As a for-profit corporate entity, the company specializes in providing advanced biomedical research services and equipment, with a primary focus on creating sophisticated animal models and genetic research tools. The organization operates as a prime contractor, consistently working with various institutes within the National Institutes of Health (NIH) to support cutting-edge scientific research initiatives.

Through its federal contract awards, Biohippo Inc. has demonstrated extensive expertise in developing complex genetic research tools, specifically custom animal models and specialized mouse strains for various NIH research institutes. The company has consistently secured purchase order contracts from multiple NIH agencies, including the National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Aging (NIA), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute on Deafness and Other Communication Disorders (NIDCD). Their services encompass constructing custom conditional knockout mice, generating specific gene-modified mouse lines, performing gene detection and quality control reporting, and providing specialized research animal models using advanced techniques like CRISPR/Cas9 technology. Most of their contracts are firm-fixed-price purchase orders ranging from $2,774 to $24,500, with no specific set-aside designations except for one Total Small Business contract. The contracts typically have completion dates within 6-12 months and support various research protocols across different medical and scientific domains.

Quick answers

What is Biohippo Inc.'s UEI?

Biohippo Inc.'s Unique Entity ID (UEI) in SAM.gov is S969JZ9MKUH3.

What is Biohippo Inc.'s CAGE code?

Biohippo Inc.'s CAGE code is 87SR1.

What is Biohippo Inc.'s primary NAICS code?

Biohippo Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Biohippo Inc. located?

Biohippo Inc.'s physical address in SAM.gov is 900 Clopper Rd #140, Gaithersburg, MD 20878, USA.

Is Biohippo Inc. registered in SAM.gov?

Yes. Biohippo Inc.'s SAM.gov registration is active through August 3, 2027.

What is Biohippo Inc.'s most recent federal award?

Biohippo Inc.'s most recent federal contract award is PLVAP1-CRE-ER mice to study vascular fenestrations in the CNS (75N95A25P00010), from National Institute of Neurological Disorders and Stroke, on December 17, 2024.

On GovTribe

See Biohippo Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors